Cargando…
Cetuximab Combined With Sonodynamic Therapy Achieves Dual-Modal Image Monitoring for the Treatment of EGFR-Sensitive Non-Small-Cell Lung Cancer
BACKGROUND: Blocking signaling by epidermal growth factor receptor (EGFR), can effectively inhibit the proliferation and differentiation of non-small-cell lung cancer (NSCLC). Additionally, an increasing number of NSCLC patients have treatment limitations caused by EGFR overexpression or mutations....
Autores principales: | Qiu, Guanhua, Xue, Lianfang, Zhu, Xiaoqi, Lu, Xiuxin, Liu, Lidong, Wang, Zhonghai, Li, Xiangdong, Huang, Cuiqing, Liu, Junjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886674/ https://www.ncbi.nlm.nih.gov/pubmed/35242698 http://dx.doi.org/10.3389/fonc.2022.756489 |
Ejemplares similares
-
Sonodynamic therapy‐assisted immunotherapy: A novel modality for cancer treatment
por: Zhang, Qianyu, et al.
Publicado: (2018) -
Hypoxia modulation by dual-drug nanoparticles for enhanced synergistic sonodynamic and starvation therapy
por: Wang, Jingxue, et al.
Publicado: (2021) -
Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy (†)
por: Sihver, Wiebke, et al.
Publicado: (2014) -
Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability
por: Goulet, Dennis R., et al.
Publicado: (2022) -
Emerging Sonodynamic Therapy‐Based Nanomedicines for Cancer Immunotherapy
por: Yang, Yunrong, et al.
Publicado: (2022)